Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endotracheal lidocaine for suctioning-induced intracranial pressure changes in children with severe traumatic brain injury
ACTRN12611000208909Phase 2Terminated
- Sponsor
- Paulo Sergio Lucas da Silva
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of lidocaine in traumatic brain injury (TBI) (2 arms), sponsored by Paulo Sergio Lucas da Silva. Primary endpoint: Mean change in intracranial pressure. Started Jan 2013; status: terminated.
02
Drugs
lidocaine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on ACTRN12611000208909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000208909.